Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  1, 154 - 158 (1995)
doi:10.1038/nm0295-154

Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury

Lenard M. Lichtenberger1, 3, Zu-Mo Wang1, Jimmy J. Romero1, Carlos Ulloa1, Joseph C. Perez1, Marie-Noëlle Giraud1 & José C. Barreto2

  1Department of Physiology and Cell Biology The University of Texas Medical School at Houston Houston, Texas 77030, USA

  2Department of Surgery The University of Texas Medical School at Houston Houston, Texas 77030, USA

  3Correspondence should be addressed to L.M.L.

The molecular basis of the injurious actions of non-steroidal anti-inflammatory drugs (NSAIDs) on the gastrointestinal (GI) tract is only partly understood. In this study we have obtained evidence, employing both in vitro and in vivo systems, that five NSAIDs have the ability to form a chemical association with zwitterionic phospholipids. Since this same class of phospholipids line the luminal aspects of the mucus gel layer to provide it with non-wettable properties, this intermolecular association may be the mechanism by which NSAIDs attenuate the hydrophobic barrier properties of the upper GI tract. Preassociating a number of NSAIDs with exogenous zwitterionic phospholipids prevented this increase in surface wettability of the mucus gel layer and protected rats against the injurious GI side-effects of these drugs, while enhancing their lipid permeability, antipyretic and anti-inflammatory activity.

REFERENCES
  1. Rainsford, K.D. Anti-inflammatory and Anti-rheumatic Drugs I, (CRC Press, Boca Raton, FL, (1985).
  2. Alexander, A.M., Veitch, G.B.A. & Wood, J.B. Anti-rheumatic and analgesic drug usage and acute gastro-intestinal bleeding in elderly patients. J. clin. Hosp. Pharm. 10, 89−93 (1985). | PubMed  | ISI | ChemPort |
  3. Jolobe, O.M.P. & Montgomery, R.D. Changing clinical pattern of gastric ulcer: Are anti-inflammatory drugs involved? Digestion 29, 164−170 (1984). | PubMed  | ISI | ChemPort |
  4. Rainsford, K.D. Mechanism of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Scand. J. Gastroenterol. 24 (suppl. 163), 9−16 (1989). | PubMed  | ISI |
  5. Graham, D.Y. Prevention of gastroduodenal injury induced by chronic nonsteroidal anti-inflammatory drug therapy. Gastroenterology 96, 675−681 (1989). | PubMed  | ISI | ChemPort |
  6. Allison, M.C., Howatson, A.G., Torrance, C.J., Lee, F.D. & Russell, R.I. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs New Engl. J. Med. 32, 749−754 (1992).
  7. Alpsten, M., Bogentoft, C., Ekenved, G. & Solvell, L. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated microgranules. Eur. J. clin. Pharmac. 22, 57−61, (1982). | ISI | ChemPort |
  8. Mojaverian, P., Rocci, M.L. Jr, Conner, D.P., Abrams, W.B. & Vlasses, P.H. Effect of food on the absorption of enteric-coated aspirin: Correlation with gastric residence time. Clin. Pharmac. Ther. 41, 11−17 (1987). | ISI | ChemPort |
  9. Whittle, B.J.R., Higgs, G.A., Eakins, K.E., Moncada, S. & Vane, J.R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284, 271−273 (1980). | PubMed  | ISI | ChemPort |
  10. Whittle, B.J.R. Temoral relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80, 94−98 (1981). | PubMed  | ISI | ChemPort |
  11. Ligumsky, M., Grossman, M.I. & Kauffman, G.L. Jr Endogenous gastric mucosal prostaglandins: Their role in mucosal integrity. Am. J. Physiol. 242, G337−341 (1982). | PubMed  | ISI | ChemPort |
  12. McCormack, K. & Brune, K. Classical absorption theory and the development of gastric mucosal damage associated with non-steroidal anti-inflammatory drugs. Archs. Toxicol. 60, 261−269 (1987). | ChemPort |
  13. Hills, B.A., Butler, B.D. & Lichtenberger, L.M. Gastric mucosal barrier: The hydrophobic lining to the lumen of the stomach. Am. J. Physiol. 244, G561−G568 (1983). | PubMed  | ISI | ChemPort |
  14. Goddard, P.J., Hills, B.A. & Lichtenberger, L.M. Does aspirin damage the canine gastric mucosa by reducing its surface hydrophobicity? Am. J. Physiol. 252, G421−G430 (1987). | PubMed  | ISI | ChemPort |
  15. Goddard, P.J., Kao, Y.-C. & Lichtenberger, L.M. Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel. Gastroenterology 98, 361−370 (1990). | PubMed  | ISI | ChemPort |
  16. Kao, Y.-C., Goddard, P.J. & Lichtenberger, L.M. Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface: Analysis with a phospholipid cytochemical stain. Gastroenterology 98, 592−606 (1990). | PubMed  | ISI | ChemPort |
  17. Kao, Y.-C., & Lichtenberger, L.M. Phospholipid- and neutral-lipid containing organelles of rat gastroduodenal mucous cells. Gastroenterology 101, 7−21 (1991). | PubMed  | ISI | ChemPort |
  18. Kao, Y.-C., & Lichtenberger, L.M. Effect of 16,16 dimethyl prostaglandin E2 on the lipidic organelles of rat gastric surface mucous cells. Gastroenterology 104, 103−113 (1993). | PubMed  | ISI | ChemPort |
  19. Adams, S.S., Hebborn, P. & Nicholson, J.S. Some aspects of the pharmacology of ibufenac, a non-steroidal anti-inflammatory agent. J. Pharm. Pharmac. 20, 305−312 (1968). | ISI | ChemPort |
  20. Ucelay, M., Lasheras, B. & Cenarruzabeitia, E. Pharmacological study of the new non-steroidal anti-inflammatory agent, 4'-Acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole) acetate. Arzheim−Forsch/Drug Res. 38, 546−551 (1988). | ChemPort |
  21. Castro, G.A., Malone, C. & Smith, S. Systemic anti-inflammatory effect associated with enteric trichinellosis in the rat. J. Parasit. 66, 407−412 (1980). | PubMed  | ISI | ChemPort |
  22. Lichtenberger, L.M., Graziani, L.A., Dial, E.J., Butler, B.D. & Hills, B.A. Role of surface-active phospholipids in gastric cytoprotection. Science 219, 1327−1329 (1983) | PubMed  | ISI | ChemPort |
  23. Chen, et al. Gastroenterology 104, A53 (1993). | ISI |
  24. Clatworthy, A.L., Castro, G.A., Budelmann, B.U. & Walters, E.T. Induction of a cellular defense reaction is accompanied by an increase in sensory neuron excitability in Aplysia. J. Neurosci. 14, 3263−3270 (1994). | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1995 Nature Publishing Group | Privacy policy